Hospital
Phc-Morgan City LP
Phc-Morgan City LP was paid $2.37M by Medicaid between Jan 2018 and Sep 2019, across 67 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoPHC-MORGAN CITY LP
MORGAN CITY, LA 70380
MORGAN CITY, LA 70380
33aNPI1093876997assigned 12/13/2006
33bProvider typeRural Acute Care Hospital
28Total paid$2.37M
24GClaims73,226
24DCodes billed67
24AFirst – last monthJan 2018 – Sep 2019
Compared with peers
Next to other Rural Acute Care Hospital providers in Louisiana
Rank by total paid#8 of 8
Median peer was paid$12.38M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TEAGUE, KATHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,167 | $1.27M | |
| 2019 | 34,059 | $1.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 16,829 | 15,185 | $955K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 6,213 | 5,555 | $606K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 9.8% | 548 | 487 | $232K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 2,335 | 2,187 | $90K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.6% | 916 | 691 | $63K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.5% | 646 | 552 | $60K |
| 80053 | Comprehensive metabolic panel | 2.2% | 5,975 | 5,227 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 7,885 | 6,819 | $51K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 1,520 | 1,309 | $32K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 775 | 489 | $22K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 631 | 528 | $20K |
| 87631 | <1% | 128 | 114 | $17K |
55 more codes
| 81001 | <1% | 5,925 | $17K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,748 | $14K |
| 80061 | Lipid panel | <1% | 1,005 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 777 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 642 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 299 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 299 | $11K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 218 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 263 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 602 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 722 | $6K |
| 84439 | <1% | 512 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 348 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $4K |
| 81025 | <1% | 621 | $4K | |
| 84484 | <1% | 600 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 359 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,740 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,616 | $3K |
| 74018 | <1% | 47 | $2K | |
| 83690 | <1% | 322 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 16 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 533 | $2K |
| 87081 | <1% | 180 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 407 | $1K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 19 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 174 | $1K |
| 82553 | <1% | 124 | $986.08 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 32 | $897.05 |
| 83525 | <1% | 62 | $811.21 | |
| 82550 | <1% | 150 | $706.51 | |
| 73562 | <1% | 49 | $653.37 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 68 | $425.99 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 95 | $425.14 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 78 | $394.97 |
| 73560 | <1% | 20 | $264.29 | |
| 83540 | <1% | 37 | $252.10 | |
| 83550 | <1% | 24 | $228.36 | |
| 83735 | <1% | 63 | $208.66 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 17 | $196.37 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 142 | $185.94 |
| 85730 | <1% | 119 | $180.50 | |
| 83880 | <1% | 12 | $169.46 | |
| 82947 | <1% | 76 | $164.36 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 25 | $132.14 |
| 85610 | <1% | 119 | $122.75 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 171 | $113.50 |
| J2704 | Injection, propofol, 10 mg | <1% | 362 | $54.31 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 357 | $43.19 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 444 | $34.94 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 17 | $5.16 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 43 | $3.36 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 26 | $2.23 |
| 99001 | 0% | 21 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 1,064 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTEAGUE, KATHY (SECRETARY)
| Provider | Location | Paid |
|---|---|---|
| Rchp-Wilmington, LLC | Wilmington, OH | $13.53M |
| Providence Hospital, LLC | Columbia, SC | $12.68M |
| Vaughan Regional Medical Center LLC | Selma, AL | $8.15M |
| Kershaw Hospital LLC | Camden, SC | $7.93M |
| Bolivar Physician Practices LLC | Cleveland, MS | $3.05M |
| Wilmington Physicians Group LLC | Wilmington, OH | $3.04M |
| Community Hospital of Andalusia LLC | Andalusia, AL | $2.27M |
| Vaughan Regional Medical Center LLC | Marion, AL | $2.15M |
| PRHC Ennis LP | Ennis, TX | $1.81M |
| Andalusia Physician Practices LLC | Andalusia, AL | $847K |
| Meadowview Physician Practice LLC | Maysville, KY | $783K |
| Logan Physician Practice LLC | Auburn, KY | $458K |
| Logan Physician Practice LLC | Russellville, KY | $317K |
| Kentucky Mso LLC | Georgetown, KY | $248K |
| Rchp-Wilmington, LLC | Wilmington, OH | $165K |
| Meadowview Physician Practice LLC | Maysville, KY | $140K |
| Amg-Southern Tennessee LLC | Monteagle, TN | $136K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $135K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $57K |
| Kershaw Hospital LLC | Lugoff, SC | $49K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.